Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis

Journal of Clinical Investigation

Volumn 108, Issue 12, 2001, Pages 1781-1788

  Shouda, Takanori ^a,b   Yoshida, Takafumi ^a,c   Hanada, Toshikatsu ^a   Wakioka, Toru ^a,d   Oishi, Masanobu ^a   Miyoshi, Kanta ^a,d   Komiya, Setsuro ^d   Kosai, Ken Ichiro ^e   Hanakawa, Yasushi ^f   Hashimoto, Koji ^f   Nagata, Kensei ^b   Yoshimura, Akihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Department of Orthopedic Surgery ^*  (Japan)

^c KURUME UNIVERSITY   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

^e GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; COLLAGEN; COMPLEMENTARY DNA; CYTOKINE; INTERFERON; INTERLEUKIN 6; INTERLEUKIN DERIVATIVE; JANUS KINASE; MESSENGER RNA; PROTEIN CIS3; REPRESSOR PROTEIN; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EDEMA; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INJECTION; MALE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIUM;

EID: 0035667907     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI13568     Document Type: Article

References (36)

1. Role of cytokines in rheumatoid arthritis
2. Rheumatoid arthritis
3. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis
4. Repeated therapy with monoclonal antibody to tumor necrosis factor alpha (cA2) in patients with rheumatoid arthritis
5. Interleukin6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor
6. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6
7. Interleukin 6 knock-out mice are resistant to antigeninduced experimental arthritis
8. Interleukin 6 plays a key role in the development of antigen-induced arthritis
9. Interleukin 6 is required for the development of collagen-induced arthritis
10. Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody
11. Negative regulation of cytokine signaling pathway
12. LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages
13. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: Evidence for an IL-10-induced pathway that is independent of STAT protein activation
14. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain
15. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130
16. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130
17. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation
18. A central role for STAT3 In IL-6-induced regulation of growth and differentiation in M1 leukemia cells
19. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
20. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome
21. Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis
22. Suppression of arthritic bone destruction by Adenovirus-mediated csk gene transfer to synoviccytes and osteoclast
23. Antigen-induced arthritis in mice
24. Collagen induced arthritis as an experimental model For rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity
25. Restraint stress-induced immunosuppression by inhibiting leukocyte migration and Th1 cytokine expression during the intraperitoneal infection of Listeria monocytogenes
26. Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4
27. The effect of a T cell-specific NF-κB inhibitor on in vitro cytokine production and collagen-induced arthritis
28. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families
29. CIS3/SOCS3 suppresses erythropoietin signaling by binding the EPO receptor and JAK2
30. Activation of the IL-4 STAT pathway in rheumatoid synovium
31. Humanized antibody to human interleukinn-6 receptor inhibits the development of collagen arthritis in cynomolugus monkeys
32. Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody
33. Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes
34. Adenovirus gene transfer causes inflammation in the brain
35. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6
36. Inhibition of acute lymphoblastic leukemia by a Jak-2 inhibitor